Actavis Says Endo Cites Wrong Precedent In False Ad Suit
Endo Pharmaceuticals Inc. can't rely on the U.S. Supreme Court's 2014 Pom Wonderful decision to claim that its suit against Actavis Inc. over generic versions of the painkiller Opana ER is...To view the full article, register now.
Already a subscriber? Click here to view full article